查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596218

呼吸吸入器市场：按产品类型、年龄层、模式、适应症和最终用户划分 - 全球预测 2025-2030

Respiratory Inhalers Market by Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), Age Group (Adults, Pediatric), Mode, Disease Indication, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年呼吸吸入器市场价值为29.6亿美元，预计到2024年将达到32.4亿美元，复合年增长率为9.74%，到2030年将达到56.8亿美元。

呼吸吸入器市场包括各种用于将药物直接输送到肺部的设备，主要用于患有气喘和慢性阻塞性肺病等慢性呼吸道疾病的人。这些吸入器的需求源于空气污染、吸烟和老年人口不断增加导致的呼吸道疾病的日益普及。其应用对于提供快速缓解和长期药物控制非常重要，从而提高患者的依从性和生活品质。最终用途多种多样，包括家庭护理场所、医院和诊所，凸显了对便携式且易于使用的设备的需求。影响市场成长的关键因素包括吸入器技术的进步，例如提供剂量追踪和患者提醒以提高用药依从性的智慧吸入器。生物疗法和数位健康技术的出现正在推动市场走向个人化医疗解决方案，并代表着巨大的潜在机会。然而，挑战依然存在，高成本、滥用的可能性以及影响市场扩张的监管障碍等限制因素。关于一次性吸入器的环境问题也引发了永续性问题。创新和研究的重点领域包括开发更环保的设备、利用机器学习演算法改进吸入技术以及整合更先进的物联网功能进行资料分析。市场越来越倾向于数位解决方案和永续实践，这表明对技术先进和环保产品的需求不断增长。与医疗保健提供者和高科技公司的合作可以提供有价值的伙伴关係来开发创新解决方案。因此，该行业必须适应监管环境，投资于研发，并克服设备滥用和负担能力等挑战。透过利用这些对消费者需求和监管环境的竞争考察，公司可以利用新机会并确保竞争优势和市场成长机会。

主要市场统计
基准年[2023] 29.6亿美元
预测年份 [2024] 32.4亿美元
预测年份 [2030] 56.8亿美元
复合年增长率（%） 9.74%

市场动态：快速发展的呼吸吸入器市场的关键市场洞察

供需的动态交互作用正在改变呼吸吸入器市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球空气污染率上升和呼吸道疾病爆发
    • 提高消费者对肺部疾病的认识
    • 政府对改善气喘治疗的兴趣日益浓厚
  • 市场限制因素
    • 政府对吸入器核准有严格的规定
  • 市场机会
    • 创新智慧吸入器简介
    • 开发有效的吸入剂配方
  • 市场挑战
    • 吸入器的不正确使用和操作问题

波特的五力：驾驭呼吸吸入器市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解呼吸吸入器市场的外部影响

外部宏观环境因素在塑造呼吸吸入器市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解呼吸吸入器市场的竞争格局

对呼吸吸入器市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵呼吸吸入器市场供应商的绩效评估

FPNV定位矩阵是评估呼吸吸入器市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划呼吸吸入器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，呼吸吸入器市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球空气污染率上升和呼吸道疾病爆发
      • 意识提升
      • 政府专注于改善气喘治疗
    • 抑制因素
      • 政府对吸入器核准的严格规定
    • 机会
      • 创新智慧吸入器简介
      • 开发有效的吸入剂配方
    • 任务
      • 吸入器的不正确使用和操作问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章呼吸吸入器市场：依产品类型

  • 干粉吸入器
  • 定量吸入器
  • 喷雾器
  • 缓雾吸入器

第七章呼吸吸入器市场：依年龄组

  • 成人
  • 小儿科

第八章呼吸吸入器市场模式

  • 数位化操作装置
  • 手动操作装置

第九章呼吸吸入器市场：依疾病适应症

  • 气喘
  • 慢性阻塞性肺病
  • 肺动脉高血压

第10章呼吸吸入器市场：依最终用途

  • 诊所和医院
  • 药局
  • 呼吸护理中心

第十一章美洲呼吸吸入器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太呼吸吸入器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲呼吸吸入器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AstraZeneca PLC
  • Beximco Pharmaceuticals Ltd.
  • CH Boehringer Sohn Ko. KG
  • Cadila Healthcare Ltd.
  • Chiesi Farmaceutici SpA
  • Cipla Limited
  • GlaxoSmithKline PLC
  • Heltman Medikal AS
  • Koninklijke Philips NV
  • Lupin Limited
  • Merck & Co., Inc.
  • Microlife Corporation
  • Novartis AG
  • Opko Health, Inc.
  • Rossmax International Ltd.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-DD5AD9F59777

The Respiratory Inhalers Market was valued at USD 2.96 billion in 2023, expected to reach USD 3.24 billion in 2024, and is projected to grow at a CAGR of 9.74%, to USD 5.68 billion by 2030.

The respiratory inhalers market encompasses a range of devices used for the delivery of medication directly into the lungs, primarily benefiting individuals with chronic respiratory conditions like asthma and COPD. The necessity for these inhalers arises from the increasing prevalence of respiratory disorders driven by air pollution, smoking, and a rising geriatric population. Their application is critical in delivering rapid relief or long-term control medication, thereby improving patient compliance and quality of life. The end-use scope spans across home care settings, hospitals, and clinics, emphasizing the need for portable and easy-to-use devices. Key factors influencing the market growth include advancements in inhaler technology, such as smart inhalers that provide dosage tracking and patient reminders, which enhance medication adherence. The emergence of biologic therapies and digital health technologies represents significant potential opportunities, pushing the market toward personalized medicine solutions. However, challenges persist, with limitations like high costs, potential for incorrect usage, and regulatory hurdles impacting market expansion. Environmental concerns regarding disposable inhalers also pose sustainability issues. For innovation and research, focus areas include developing more eco-friendly devices, improving inhalation techniques through machine learning algorithms, and integrating more advanced IoT features for data analytics. The market shows a growing inclination towards digital solutions and sustainable practices, indicating an upward trend in demand for technologically advanced and environmentally friendly products. Collaborations with healthcare providers and tech companies could provide valuable partnerships to develop innovative solutions. Thus, the industry must navigate regulatory landscapes and invest in R&D to overcome challenges like device misuse and affordability. By leveraging these insights into consumer demands and regulatory setups, companies can capitalize on emerging opportunities, ensuring competitive advantage and market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.96 billion
Estimated Year [2024] USD 3.24 billion
Forecast Year [2030] USD 5.68 billion
CAGR (%) 9.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Respiratory Inhalers Market

The Respiratory Inhalers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in air pollution rate worldwide and occurrence of respiratory disorders
    • Increasing consumer awareness of pulmonary disorders
    • Growing government focus on improving asthma care
  • Market Restraints
    • Stringent regulations for inhaler approvals by the government
  • Market Opportunities
    • Introduction of innovative smart inhalers
    • Development of effective inhaler medication formulations
  • Market Challenges
    • Incorrect usage and operational issues in inhalers

Porter's Five Forces: A Strategic Tool for Navigating the Respiratory Inhalers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Respiratory Inhalers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Respiratory Inhalers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Respiratory Inhalers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Respiratory Inhalers Market

A detailed market share analysis in the Respiratory Inhalers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Respiratory Inhalers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Respiratory Inhalers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Respiratory Inhalers Market

A strategic analysis of the Respiratory Inhalers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Inhalers Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Beximco Pharmaceuticals Ltd., C.H. Boehringer Sohn Ko. KG, Cadila Healthcare Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, GlaxoSmithKline PLC, Heltman Medikal A.S., Koninklijke Philips N.V., Lupin Limited, Merck & Co., Inc., Microlife Corporation, Novartis AG, Opko Health, Inc., Rossmax International Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Respiratory Inhalers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer, and Soft Mist Inhalers.
  • Based on Age Group, market is studied across Adults and Pediatric.
  • Based on Mode, market is studied across Digitally Operated Devices and Manually Operated Devices.
  • Based on Disease Indication, market is studied across Asthma, Chronic Obstructive Pulmonary Disease, and Pulmonary Arterial Hypertension.
  • Based on End-Use, market is studied across Clinics & Hospitals, Pharmacies, and Respiratory Care Center.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in air pollution rate worldwide and occurrence of respiratory disorders
      • 5.1.1.2. Increasing consumer awareness of pulmonary disorders
      • 5.1.1.3. Growing government focus on improving asthma care
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations for inhaler approvals by the government
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of innovative smart inhalers
      • 5.1.3.2. Development of effective inhaler medication formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Incorrect usage and operational issues in inhalers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Respiratory Inhalers Market, by Product Type

  • 6.1. Introduction
  • 6.2. Dry Powder Inhaler
  • 6.3. Metered Dose Inhaler
  • 6.4. Nebulizer
  • 6.5. Soft Mist Inhalers

7. Respiratory Inhalers Market, by Age Group

  • 7.1. Introduction
  • 7.2. Adults
  • 7.3. Pediatric

8. Respiratory Inhalers Market, by Mode

  • 8.1. Introduction
  • 8.2. Digitally Operated Devices
  • 8.3. Manually Operated Devices

9. Respiratory Inhalers Market, by Disease Indication

  • 9.1. Introduction
  • 9.2. Asthma
  • 9.3. Chronic Obstructive Pulmonary Disease
  • 9.4. Pulmonary Arterial Hypertension

10. Respiratory Inhalers Market, by End-Use

  • 10.1. Introduction
  • 10.2. Clinics & Hospitals
  • 10.3. Pharmacies
  • 10.4. Respiratory Care Center

11. Americas Respiratory Inhalers Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Respiratory Inhalers Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Respiratory Inhalers Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca PLC
  • 2. Beximco Pharmaceuticals Ltd.
  • 3. C.H. Boehringer Sohn Ko. KG
  • 4. Cadila Healthcare Ltd.
  • 5. Chiesi Farmaceutici S.p.A.
  • 6. Cipla Limited
  • 7. GlaxoSmithKline PLC
  • 8. Heltman Medikal A.S.
  • 9. Koninklijke Philips N.V.
  • 10. Lupin Limited
  • 11. Merck & Co., Inc.
  • 12. Microlife Corporation
  • 13. Novartis AG
  • 14. Opko Health, Inc.
  • 15. Rossmax International Ltd.
  • 16. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. RESPIRATORY INHALERS MARKET RESEARCH PROCESS
  • FIGURE 2. RESPIRATORY INHALERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RESPIRATORY INHALERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RESPIRATORY INHALERS MARKET DYNAMICS
  • TABLE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DIGITALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MANUALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RESPIRATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2023